Related Experiment Videos
A new polymorphism in the gene for the dopamine D2 receptor
1Department of Neurology, Texas Tech University Health Sciences Center, Lubbock 79430, USA.
Human Genetics
|May 1, 1995
Summary
Researchers discovered a novel dopamine D2 receptor gene polymorphism using SSCP analysis. This 3'-untranslated region insertion was found at a 0.07 frequency in CEPH parent samples.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- The dopamine D2 receptor (DRD2) plays a crucial role in neurotransmission.
- Genetic variations in DRD2 may influence receptor function and susceptibility to neurological disorders.
- Identifying novel polymorphisms is essential for understanding genetic diversity and potential disease associations.
Purpose of the Study:
- To identify and characterize novel polymorphisms within the dopamine D2 receptor gene.
- To investigate the frequency of the identified polymorphism in a specific human population.
Main Methods:
- Single-stranded conformational polymorphism (SSCP) analysis was employed for polymorphism screening.
- DNA sequencing was performed to determine the precise nature of the genetic variation.
- Genotyping of Centre d'Etude du Polymorphisme Humain (CEPH) parents was conducted to assess allele frequency.
Main Results:
- A new polymorphism was identified in the dopamine D2 receptor gene.
- Sequencing revealed the polymorphism to be an insertion at a BsoF1 restriction site.
- This 3 -untranslated region polymorphism was observed with a frequency of 0.07 in the CEPH parent cohort.
Conclusions:
- A novel insertion polymorphism has been characterized in the 3 -untranslated region of the dopamine D2 receptor gene.
- The identified polymorphism is present at a detectable frequency in the studied population.
- This finding contributes to the catalog of known dopamine D2 receptor genetic variations, potentially relevant for future association studies.